{
    "Trade/Device Name(s)": [
        "MAS Immunosuppressant Controls"
    ],
    "Submitter Information": "Microgenics Corporation",
    "510(k) Number": "K051074",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022041"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LAS"
    ],
    "Summary Letter Date": "June 6, 2005",
    "Summary Letter Received Date": "April 29, 2005",
    "Submission Date": "April 25, 2005",
    "Regulation Number(s)": [
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "transplant"
    ],
    "Analyte(s)": [
        "Cyclosporine",
        "Sirolimus",
        "Tacrolimus"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for MAS Immunosuppressant Controls used as in vitro quality control material to monitor laboratory precision for cyclosporine, sirolimus, and tacrolimus testing.",
    "Indications for Use Summary": "For use as assayed quality control material to monitor the precision of laboratory testing procedures for cyclosporine, sirolimus, and tacrolimus.",
    "fda_folder": "Toxicology"
}